Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
Eupraxia Pharmaceuticals...
Source: lelezard.com
Stay updated with breaking news from Eupraxia Diffuspheretm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.